Showing results (261-270 of 624) with videos related to

Sort By:
Pageof 63
Onkologie|February 1, 1988
Deoxycoformycin in therapy of refractory lymphoid neoplasmsA D Ho, J Thaler, R Kuse, et al.
Leukemia|April 1, 1989
Acute myeloblastic leukemia with t(8;21) following Philadelphia positive acute lymphoblastic leukemiaM R De Cuia, G Alimena, R Gastaldi, et al.
Oncotarget|October 31, 2015
Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibitionRoberto Gomez-Casal, Michael W Epperly, Hong Wang, et al.
Ophthalmic Plastic and Reconstructive Surgery|April 29, 1998
Rate of vascularization of coralline hydroxyapatite spherical implants pretreated with saline/gentamicin, rTGF-beta 2, and autogenous plasmaD E Holck, J J Dutton, A Proia, et al.
Biological Psychiatry|August 1, 2015
Pituitary Adenylate Cyclase-Activating Polypeptide Disrupts Motivation, Social Interaction, and Attention in Male Sprague Dawley RatsRachel J Donahue, Archana Venkataraman, F Ivy Carroll, et al.
Haematologica|November 1, 1989
Recombinant alpha interferon in the treatment of low-grade non-Hodgkin's lymphoma: results of a cooperative phase II trial in 31 patientsL Mantovani, C Guglielmi, M Martelli, et al.
Leukemia & Lymphoma|July 27, 2016
Effect of Hemopoietic Growth Factors on the Proliferation of Acute Myeloid and Lymphoid LeukemiasM Aglietta, L de Felice, A Stacchini, et al.
Leukemia & Lymphoma|January 1, 1994
Deoxycoformycin induces long-lasting remissions in hairy cell leukemia: clinical and biological results of two different regimensL Annino, A Ferrari, F Giona, et al.
Bone Marrow Transplantation|December 1, 1994
High-dose therapy and autologous bone marrow transplantation for intermediate and high grade non-Hodgkin's lymphoma in patients aged 55 years and over: results from the European Group for Bone Marrow Transplantation. The EBMT Lymphoma Working PartyJ W Sweetenham, R Pearce, T Philip, et al.
Haematologica|January 1, 1997
Analysis of the risk of solid tumor following Hodgkin's diseaseR Maurizi Enrici, A P Anselmo, M F Osti, et al.
Pageof 63